Pharming Group reports third quarter 2023 financial results
Financial updatesPharming Group N.V. presents its preliminary, unaudited financial report for the three months ended September 30, 2023.
2023
Pharming Group to report third quarter 2023 financial results on October 26
Financial updatesPharming Group N.V. confirms it will report its preliminary (unaudited) third quarter 2023 financial results, for the period ended September 30, on Thursday, October 26, 2023.
Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
Corporate updatesPharming Group N.V. announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted all proposals on the EGM agenda.
Pharming shortlisted for prestigious Scrip awards 2023
Other updatesPharming shortlisted in two categories, including “Biotech Company of the Year” and “Best New Drug”
Pharming Group to participate in September investor conferences
Conference attendancePharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the U.S. in the month of September:
Pharming Group to convene Extraordinary General Meeting of Shareholders
Financial updatesPharming Group N.V. announces it will hold an Extraordinary General Meeting of Shareholders (EGM) on Monday, September 25, 2023 at 14:00 CEST.
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
Clinical trialsSingle-arm Phase III study in Japan evaluating leniolisib in patients aged 12 years and older with APDS, a rare primary immunodeficiency
Pharming Group reports second quarter and first half 2023 financial results
Financial updatesPharming Group N.V. presents its preliminary (unaudited) financial report for the second quarter and first half ended June 30, 2023.
Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board
Corporate updatesPharming Group N.V. announces today that the Board of Directors has nominated Dr. Richard Peters to become Pharming’s new Chairman.
Pharming Group to report second quarter and first half 2023 financial results on August 3
Financial updatesPharming Group N.V. confirms it will report its preliminary (unaudited) second quarter and first half 2023 financial results, for the period ended June 30, on Thursday, August 3, 2023.